fda compounding pharmacy tirzepatide 🚨March 19! If you haven’t heard, March 19 is the last day to get your compounded according to the new ruling by FDA. If you have refills, now is the time to get them. Stock up before it’s Compounded Tirzepatide (GLP-1/GIP)

The Retatrutide starting dose is 2 mg once weekly, gradually increasing over several months to a target maintenance dose of 12 mg per week

Retatrutide sold for laboratory research purposes to verified institutions is legal under applicable regulations

The distribution of protein intake across the day is as important as total daily amount for optimizing muscle protein synthesis and preservation during GLP-1 therapy

Where required, dispensing may occur only pursuant to a valid patientspecific prescription and an established prescriberpatient relationship

We recommend our patients use these drops four times each day